மருத்துவ சாதனம் உற்பத்தியாளர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ சாதனம் உற்பத்தியாளர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ சாதனம் உற்பத்தியாளர் Today - Breaking & Trending Today

Vascular Access Devices Market Size Worth $8.03 Billion By 2028 | Exclusive Study by Polaris Market Research


Share this article
Share this article
USD 8.03 billion by 2028 according to a new study conducted by 
Polaris Market Research. the market is anticipated to register a 
CAGR of
7.4%
from 2021 – 2028 Technological advancements in the development of medical devices coupled with a rise in the number of surgeries conducted across the globe requiring the use of advanced medical devices are making a higher impact on the market growth. In addition to this, increasing cases of blood transfusions, especially in major developed countries, and growing patient s need for central venous access during long-term intravenous therapy such as chemotherapy and antimicrobial therapy is further fostering the market growth. Furthermore, a rise in government spending for the improvement of healthcare infrastructure is expected to support market development in the longer run. ....

New York , United States , Saudi Arabia , South Africa , South Korea , B Braun Melsungen , Asia Pacific , Biotechnology Companies , Polaris Market Research , Administration Of Drugs , Navilyst Medical Inc , Baxter International , Research Summary On Vascular Access Devices Market , Teleflex Incorporated , Smiths Medical Inc , Terumo Corporation , Fresenius Medical Care Ag Co , Edwards Lifesciences Corporation , Becton Dickinson , Nipro Medical Corporation , World Health Organization , C Rbard Inc , Research Institutes , Surgery Centers , Diagnostics Centers , Polaris Market ,

Doug Godshall to Chair Gala Therapeutics Board of Directors


Doug Godshall to Chair Gala Therapeutics Board of Directors
News provided by
Share this article
Share this article
SAN CARLOS, Calif., March 2, 2021 /PRNewswire/  Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat chronic bronchitis and other pulmonary diseases, announced today that it has appointed Douglas Godshall to chair of its Board of Directors. Since 2017, Godshall has been President and CEO of Shockwave Medical, a medical device company developing a proprietary non-invasive treatment for atherosclerotic cardiovascular disease that locally delivers sonic pressure waves to calcified plaque. From 2006 to 2016, Godshall was CEO and a director of HeartWare International, a medical device company created by Apple Tree Partners (ATP). HeartWare was acquired by Medtronic for $1.1 billion in 2016.  Before HeartWare, Godshall held various executive leadership roles at Boston Scientific. ....

New York , United States , United Kingdom , City Of , San Carlos , Northeastern University , San Francisco , Doug Godshall , Jonathan Waldstreicher , Douglas Godshall , Seth Harrison , Heartware International , Lafayette College , Boston Scientific , Device Manufacturer Association , Eyepoint Pharmaceuticals , Gala Therapeutics Inc , Gala Therapeutics , Shockwave Medical , Apple Tree Partners , Before Heartware , Medical Device Manufacturer , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் ,